MX2015006096A - Leucocitos como celulas de administracion para imagen y terapia de enfermedad. - Google Patents
Leucocitos como celulas de administracion para imagen y terapia de enfermedad.Info
- Publication number
- MX2015006096A MX2015006096A MX2015006096A MX2015006096A MX2015006096A MX 2015006096 A MX2015006096 A MX 2015006096A MX 2015006096 A MX2015006096 A MX 2015006096A MX 2015006096 A MX2015006096 A MX 2015006096A MX 2015006096 A MX2015006096 A MX 2015006096A
- Authority
- MX
- Mexico
- Prior art keywords
- leukocytes
- imaging
- disease therapy
- delivery cells
- delivery
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title abstract 2
- 210000000265 leukocyte Anatomy 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 238000002428 photodynamic therapy Methods 0.000 abstract 1
- 238000002626 targeted therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
- A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Se describen métodos teranósticos en la presente, que son útiles en la diagnosis y/o tratamiento de infección, inflamación y/o cáncer. Los métodos utilizan leucocitos que se presentan en la naturaleza para la terapia fotodinámica e imagen in situ y para la administración de terapias apuntadas a la infección, inflamación y/o cáncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261728083P | 2012-11-19 | 2012-11-19 | |
PCT/US2013/070515 WO2014078768A1 (en) | 2012-11-19 | 2013-11-18 | Leukocytes as delivery cells for imaging and disease therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015006096A true MX2015006096A (es) | 2015-12-01 |
Family
ID=50731749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015006096A MX2015006096A (es) | 2012-11-19 | 2013-11-18 | Leucocitos como celulas de administracion para imagen y terapia de enfermedad. |
Country Status (3)
Country | Link |
---|---|
US (1) | US20150224211A1 (es) |
MX (1) | MX2015006096A (es) |
WO (1) | WO2014078768A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL412787A1 (pl) * | 2015-06-22 | 2017-01-02 | Magdalena Król | Oparty na makrofagach celowany system dostarczania związków związanych z ferrytyną |
CN109568269B (zh) * | 2018-10-19 | 2021-12-21 | 广州医科大学 | 一种具有诊疗功能外泌体及其制备方法 |
CN112138157B (zh) * | 2020-09-29 | 2022-02-18 | 同济大学 | 一种光学控制的粒细胞生物制剂及其制备与应用 |
CN114469865B (zh) * | 2022-03-17 | 2023-09-22 | 中国医学科学院输血研究所 | 一种与血细胞膜结合的脂质体药物载体及其制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60229363D1 (de) * | 2001-03-30 | 2008-11-27 | Ghc Res Dev Corp | Monozyte-spezifisches teilchenförmiges verabreichungsvehikel |
IL168184A (en) * | 2005-04-21 | 2011-11-30 | Univ Ariel Res & Dev Co Ltd | Use of a ligand-photosensitizer conjugate in combination with a chemiluminescent agent in the manufacture of a medicament for photodynamic therapy |
US20130243741A1 (en) * | 2010-09-21 | 2013-09-19 | Kansas State University Research Foundation | Renilla/gaussia transfected cells as a light source for in-situ photodynamic therapy of cancer |
-
2013
- 2013-11-18 MX MX2015006096A patent/MX2015006096A/es unknown
- 2013-11-18 WO PCT/US2013/070515 patent/WO2014078768A1/en active Application Filing
-
2015
- 2015-04-23 US US14/694,511 patent/US20150224211A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2014078768A1 (en) | 2014-05-22 |
US20150224211A1 (en) | 2015-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020201329C1 (en) | Conjugates for treating diseases caused by PSMA expressing cells | |
MX2019010601A (es) | Terapia de combinacion para tratar cancer. | |
MX2016007351A (es) | Terapia de combinacion para tratar cancer. | |
MX366804B (es) | Translocaciones de la r-espondina y sus metodos de uso. | |
PH12016501728A1 (en) | Anti-angiogenesis therapy for the treatment of ovarian cancer | |
MX2021010672A (es) | Uso de un anticuerpo que tiene la capacidad para ligarse a clnd6 en el tratamiento o prevención de cáncer. | |
WO2015009726A3 (en) | Medical uses of cd38 agonists | |
AR082340A1 (es) | Metodos y composiciones para la terapia del cancer de higado | |
AU2011328009A8 (en) | Compounds and methods for treating pain | |
EA201400625A1 (ru) | Антитела против pd-l1 и их применение | |
TR201904980T4 (tr) | Bir B-Raf inhibitörü, bir EGFR inhibitörü ve isteğe bağlı olarak bir PI3K-alfa inhibitörü içeren farmasötik kombinasyonlar. | |
TW201611843A (en) | Methods of treatment with arginine deiminase | |
PH12015500252A1 (en) | Niclosamide for the treatment of solid tumors | |
EA201201464A1 (ru) | Новая комбинированная терапия для лечения онкологических и фиброзных заболеваний | |
MX360189B (es) | Terapia de combinacion para el tratamiento de glioblastoma. | |
IN2014MN01945A (es) | ||
MX2018000052A (es) | Composiciones y métodos para la terapia combinada con virus del dengue y celulas dendríticas. | |
MX2015006096A (es) | Leucocitos como celulas de administracion para imagen y terapia de enfermedad. | |
MX359209B (es) | Terapia de combinacion de procaspasa para gliobastoma. | |
WO2013106766A3 (en) | THERAPEUTIC INDICATIONS OF miR-1291 | |
NZ704554A (en) | Combination therapy of a smac mimetic and gm-csf | |
MX2014012535A (es) | Terapia de combinacion de anticuerpos anti-mif y quimioterapeuticos. | |
MX2012003287A (es) | Uso de la identificacion microambiental de sparc en el tratamiento del cancer. | |
PH12014502464A1 (en) | Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases | |
UA88769U (uk) | Спосіб профілактики та лікування доброякісних дисплазій молочних залоз у жінок з ранніми втратами вагітності |